Abstract

Argentina was the first country that enacted regulatory criteria to assess if organisms resulting from new breeding techniques (NBTs) are to be regarded as genetically modified organisms (GMOs) or not. The country has now accumulated 4 year of experience applying such criteria, reaching a considerable number of cases, composed mostly of gene-edited plants, animals, and microorganisms of agricultural use. This article explores the effects on economic innovation of such regulatory experience. This is done by comparing the cases of products derived from gene editing and other NBTs that have been presented to the regulatory system, against the cases of GMOs that have been deregulated in the country. Albeit preliminary, this analysis suggests that products from gene editing will have different profiles and market release rates compared with the first wave of products from the so called “modern biotechnology.” Gene editing products seems to follow a much faster development rate from bench to market. Such development is driven by a more diverse group of developers, and led mostly by small and medium enterprises (SMEs) and public research institutions. In addition, product profiles are also more diversified in terms of traits and organisms. The inferences of these findings for the agricultural and biotechnology sectors, particularly in developing countries, are discussed.

Highlights

  • The Argentine regulatory system for modern biotechnology applied to agriculture is recognized worldwide for being among the most experienced ones (Vicien and Trigo, 2017)

  • This article has compared apparent trends amongst technologies presented to the Argentine regulatory system for agricultural biotechnology

  • This was done with the purpose of detecting emerging opportunities for strengthening local innovation processes in the agricultural sector

Read more

Summary

Introduction

The Argentine regulatory system for modern biotechnology applied to agriculture is recognized worldwide for being among the most experienced ones (Vicien and Trigo, 2017). One of the current issues in development of agricultural biotechnology is analyzed : the impact of regulatory requirements on innovations based on gene editing and other NBTs. An analysis of the Argentine experience may allow some conclusions to be drawn regarding the potential impacts on the agriculture and the biotechnology sectors.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call